Evidence for the use of curcumin in radioprotection and radiosensitization
Alberto Boretti
Abstract
Curcumin has antineoplastic properties and is considered a chemotherapeutic and chemopreventive agent. Curcumin may be associated with radiation therapy (RT) as a radiosensitizer for cancer cells and a radioprotector for normal cells. In principle, it may result in a reduction of RT dosage for the same therapeutic effect on cancer cells, and further reduced damage to normal cells. Though the overall level of evidence is modest, limited to in vivo and in vitro experiences and practically no clinical trials, as the risks of adverse effects are extremely low, it is reasonable to promote the general supplementation with curcumin during RT targeting the reduction of side effects through anti-inflammatory mechanisms.
Topics & Concepts
CurcuminRadiosensitizerIn vivoMedicinePharmacologyAdverse effectIn vitroCancerCancer researchRadiation therapyInternal medicineChemistryBiologyBiotechnologyBiochemistryCurcumin's Biomedical ApplicationsEffects of Radiation ExposureHidradenitis Suppurativa and Treatments